1. Li, M.,et al. KALRN Mutations Promote Anti-tumor Immunity and Immunotherapy Response in Cancer. Journal for Immunotherapy of Cancer. 2020;8:e000293.
2. Li, M.,et al. Retrospective prediction of the epidemic trend of COVID-19 in Wuhan at four phases. Journal of Medical Virology, 2021,93(4), 2493–2498.
3. Zhang, W.#, Chen, Y.#, Li, M.#, et al. A PDA-Functionalized 3D Lung Scaffold Bioplatform to Construct Complicated Breast Tumor Microenvironment for Anticancer Drug Screening and Immunotherapy. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 2023, 10(26), e2302855.
4. Li, M., et al. Identifying novel factors associated with COVID-19 transmission and fatality using the machine learning approach. Science of the Total Environment. 764 (2021): 142810.(SCI高被引论文)
5. Li, M., et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty 9, 45 (2020). (SCI高被引论文,引用量超2000,杂志引用量前5文章,BMC杂志社颁发‘Infectious Diseases of Poverty Excellent Article Award 2016-2020’奖项)
6. Li, M., et al. An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles. Communications Biology. 3, 505 (2020).
7. Li, M*,et al. (2023). Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data. Frontiers in immunology, 14, 1090838.